These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17908944)

  • 1. Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives.
    Seifert K; Lemke A; Croft SL; Kayser O
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4525-8. PubMed ID: 17908944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
    Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
    Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial ring-substituted ether phospholipids.
    Avlonitis N; Lekka E; Detsi A; Koufaki M; Calogeropoulou T; Scoulica E; Siapi E; Kyrikou I; Mavromoustakos T; Tsotinis A; Grdadolnik SG; Makriyannis A
    J Med Chem; 2003 Feb; 46(5):755-67. PubMed ID: 12593656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
    Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
    Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
    Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
    Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
    Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
    Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
    Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylthiosemicarbazones as antileishmanial agents.
    Manzano JI; Cochet F; Boucherle B; Gómez-Pérez V; Boumendjel A; Gamarro F; Peuchmaur M
    Eur J Med Chem; 2016 Nov; 123():161-170. PubMed ID: 27475107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
    Castera-Ducros C; Paloque L; Verhaeghe P; Casanova M; Cantelli C; Hutter S; Tanguy F; Laget M; Remusat V; Cohen A; Crozet MD; Rathelot P; Azas N; Vanelle P
    Bioorg Med Chem; 2013 Nov; 21(22):7155-64. PubMed ID: 24080103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bisbenzimidazoles with antileishmanial effectiveness.
    Mayence A; Pietka A; Collins MS; Cushion MT; Tekwani BL; Huang TL; Vanden Eynde JJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2658-61. PubMed ID: 18367395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
    Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
    Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antileishmanial efficacy of novel quinazolinone derivatives.
    Prinsloo IF; Zuma NH; Aucamp J; N'Da DD
    Chem Biol Drug Des; 2021 Feb; 97(2):383-398. PubMed ID: 32914553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
    Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
    Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
    Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.
    Guglielmo S; Bertinaria M; Rolando B; Crosetti M; Fruttero R; Yardley V; Croft SL; Gasco A
    Eur J Med Chem; 2009 Dec; 44(12):5071-9. PubMed ID: 19811859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.
    Bharate SB; Bharate JB; Khan SI; Tekwani BL; Jacob MR; Mudududdla R; Yadav RR; Singh B; Sharma PR; Maity S; Singh B; Khan IA; Vishwakarma RA
    Eur J Med Chem; 2013 May; 63():435-43. PubMed ID: 23517732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.